Moebio is he talent development initiative of Biocat to accelerate healthcare entrepreneurship.
Design Health Barcelona (d·HEALTH Barcelona) Is the full-time program of MOEBIO, inspired and modeled in the prestigiousStanford University's Biodesign Fellowshipthat seeks to train a team of fellows in the process of biodesign to develop innovative solutions.
Presentation of CRAASH Barcelona, the new project of Biocat (Moebio Barcelona). The initiative is a 12-week program that helps European research teams launch successful device, diagnostic and e-/digital health innovations to improve health and patient care.
Biocat has experience in accelerating healthcare projects and developing talent since 2008. In 10 years, Biocat has invested over €11 million, distributed in 300 programs attended by more than 2,300 students. By leveraging its expert, industry experienced, staff and extended network, Biocat has successfully accelerated 96 life sciences projects that generated 300 new job positions, increased the rate of successful commercialization and reduced the time to next phase. In 2013, in order to increase the impact of these strategic activities. Biocat launched Moebio, a new initiative that brings together diferent training programs to accelerate entrepreneurship and innovation in healthcare, that counts with the support of EIT Health. Moebio is ranked as one of the top accelerators in Europe according to rankings by Digitalhealth.careers, Mobile World Capital, Tech EU and HealthStartup.
Design Health Barcelona (d·HEALTH Barcelona) is a 9-month postgraduate program to develop entrepreneurs and future leaders in healthcare innovation. The course, based on the prestigious Stanford University's Biodesign Fellowship, has a needs-driven innovation focus and it guides multidisciplinary groups of students through a full cycle of innovation, from needs identification to designing and prototyping a viable solution, as well as searching for funding.
www.moebio.org
MOEBIO is a disruptive talent development initiative of Biocat where life sciences, health, business and technology meet in a new level to accelerate entrepreneurship in healthcare. It is an integral, new educational program focused on solving society's great problems and challenges by creating the future generation of innovators in healthcare.
Design Health Barcelona is the flagship of MOEBIO. A Higher Education Program inspired in the prestigious Stanford University's Biodesign Fellowship.
Presentation of CRAASH Barcelona, the new project of Biocat (Moebio Barcelona). The initiative is a 12-week program that helps European research teams launch successful device, diagnostic and e-/digital health innovations to improve health and patient care.
Biocat has experience in accelerating healthcare projects and developing talent since 2008. In 10 years, Biocat has invested over €11 million, distributed in 300 programs attended by more than 2,300 students. By leveraging its expert, industry experienced, staff and extended network, Biocat has successfully accelerated 96 life sciences projects that generated 300 new job positions, increased the rate of successful commercialization and reduced the time to next phase. In 2013, in order to increase the impact of these strategic activities. Biocat launched Moebio, a new initiative that brings together diferent training programs to accelerate entrepreneurship and innovation in healthcare, that counts with the support of EIT Health. Moebio is ranked as one of the top accelerators in Europe according to rankings by Digitalhealth.careers, Mobile World Capital, Tech EU and HealthStartup.
Design Health Barcelona (d·HEALTH Barcelona) is a 9-month postgraduate program to develop entrepreneurs and future leaders in healthcare innovation. The course, based on the prestigious Stanford University's Biodesign Fellowship, has a needs-driven innovation focus and it guides multidisciplinary groups of students through a full cycle of innovation, from needs identification to designing and prototyping a viable solution, as well as searching for funding.
www.moebio.org
MOEBIO is a disruptive talent development initiative of Biocat where life sciences, health, business and technology meet in a new level to accelerate entrepreneurship in healthcare. It is an integral, new educational program focused on solving society's great problems and challenges by creating the future generation of innovators in healthcare.
Design Health Barcelona is the flagship of MOEBIO. A Higher Education Program inspired in the prestigious Stanford University's Biodesign Fellowship.
Increasing the success rate of developing startup-corporate partnerships by a structured program to build and validate a joint value story
by Kors van Wyngaarden, Medical Officer @Philips HealthWorks
Based on extensive experience in engaging with startups in 12 weeks programs Philips HealthWorks is continuously tweaking their approach to increase the value of sustainable partnerships between Philips and Healthcare startups. Kors will share how HealthWorks uses a structured approach, stakeholder and ecosystem engagements to help startups increase their own value and, in parallel, to build and validate the partnership value story.
Overview of Lodestone Logic services including business intelligence, strategic planning, and project execution. This presentation also includes a summary of Lodestone Logic's media channels and web presence.
This report has been developed by Medicus AI, a leading technology company supporting the diagnostic testing partners with an innovative digital health solution.
We embarked on this study to better assess and understand the challenges facing medical biologists and the healthcare industry, and to identify solutions to support a new era of healthcare.
The research included over 2,200 survey participants, and almost 20 expert interviews, and was completed in December 2020.
Business Model Design for successful Digital Health Startups in Europe | eHea...eHealth HUB
The “Business Model Design for successful Digital Health Startups in Europe” eHealth HUB Smart Guide is specifically crafted for early-stage startups, and addressing the key issues that they face when dealing with their business model.
This guide has four sections:
1. Digital Health in Europe
2. Using the “Lean Startup” approach to boost successful business models
3. Successful eHealth business models in Europe
4. How to assess digital health business models
The Observatory of Innovation in Healthcare Management in Catalonia is the instrument used by the Catalan health system to catalogue the efforts made by organisations in innovating in several spheres of management. See more information at http://oigs.gencat.cat
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014IKT-Norge
Lars Kalfhaus
Country Manager Roche Diabetes Care (ES)
Connect, Engage and Take Decisions
Opportunities and Challenges of Telemedicine Implementation
EHiN 2014, IKT-Norge og HOD
Tomorrow’s Lab Today: Focus areas for medical biology and diagnostic testing ...Serene Touma
Healthcare will require a new approach and tools to support new patient expectations in 2020. A patient-centric approach to healthcare will be more relevant than ever.
Covid-19 has uncovered new challenges and weaknesses in care that are dependent on a centralized set-up.
What is becoming more and more clear is that diagnostic labs need to evolve and up their game to stay relevant. This will continue to bring value to patients throughout the healthcare journey.
A key focus in 2021 will be taking a look at building and maintaining better relationships between private and public players in patient care.
Healthcare, from Products to Solutions Exploring some of the latest initiativ...Alix Aubert
with high-level healthcare executives. Today, through Life Science Talks, we have decided to make some of this information available
to the professional community at large, provided it is non-confidential, of public interest, and likely to spark interesting partnerships in
the future.
This white paper therefore condenses data drawn from a number of informative meetings with decision makers in the European
healthcare sector during 2013 and 2014. More specifically, it is the result of an edition of Life science Talks dedicated to this subject
and held in Paris, in May 2014.
The discussions at this event were admirably moderated by Silvia Ondategui Parra, partner at EY, and were punctuated by keynotes
from leading stakeholders in European healthcare: Emmanuel Gomez, CNAM-TS, Head of Disease Management Programmes; Dr Rick
Greville, ABPI, Director of Wales and International Affairs; Thierry Zylberberg, Orange, Head of Orange Healthcare; Miguel Bernabeu,
Alcon (Novartis), Global Head of Market Access, Pricing and HEOR; Yvoine McCourt, Air Liquide, Head of Home Healthcare
International Development; Olivier Croly, GE Healthcare IT, GM Europe. Again, we thank them for sharing their views, their concerns,
and for outlining their projects in Europe within our forum.
Biocat is the institution that brings together the life sciences and healthcare innovation community in Catalonia.
Created in 2006 at the behest of the Government of Catalonia, Biocat’s mission is to maximize the economic and social impact of the life sciences and healthcare innovation of the BioRegion.
Biocat focuses its strategy on different key points:
- Raising awareness and promoting the ecosystem, creating tools and strategies for improving the knowledge of the Catalan healthcare sector and increasing its projection both at home and abroad, with the aim of positioning the BioRegion as an international reference.
- Providing innovative training and developing talent, by designing and executing programs and initiatives to improve talent and entrepreneurship considered essential factors for the growth of the sector.
- Accelerating technology transfer and business growth by supporting and carrying out activities for increasing the value of the sector, placing special emphasis on the added value of research, knowledge and technology transfer, internationalization and access to capital.
Increasing the success rate of developing startup-corporate partnerships by a structured program to build and validate a joint value story
by Kors van Wyngaarden, Medical Officer @Philips HealthWorks
Based on extensive experience in engaging with startups in 12 weeks programs Philips HealthWorks is continuously tweaking their approach to increase the value of sustainable partnerships between Philips and Healthcare startups. Kors will share how HealthWorks uses a structured approach, stakeholder and ecosystem engagements to help startups increase their own value and, in parallel, to build and validate the partnership value story.
Overview of Lodestone Logic services including business intelligence, strategic planning, and project execution. This presentation also includes a summary of Lodestone Logic's media channels and web presence.
This report has been developed by Medicus AI, a leading technology company supporting the diagnostic testing partners with an innovative digital health solution.
We embarked on this study to better assess and understand the challenges facing medical biologists and the healthcare industry, and to identify solutions to support a new era of healthcare.
The research included over 2,200 survey participants, and almost 20 expert interviews, and was completed in December 2020.
Business Model Design for successful Digital Health Startups in Europe | eHea...eHealth HUB
The “Business Model Design for successful Digital Health Startups in Europe” eHealth HUB Smart Guide is specifically crafted for early-stage startups, and addressing the key issues that they face when dealing with their business model.
This guide has four sections:
1. Digital Health in Europe
2. Using the “Lean Startup” approach to boost successful business models
3. Successful eHealth business models in Europe
4. How to assess digital health business models
The Observatory of Innovation in Healthcare Management in Catalonia is the instrument used by the Catalan health system to catalogue the efforts made by organisations in innovating in several spheres of management. See more information at http://oigs.gencat.cat
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014IKT-Norge
Lars Kalfhaus
Country Manager Roche Diabetes Care (ES)
Connect, Engage and Take Decisions
Opportunities and Challenges of Telemedicine Implementation
EHiN 2014, IKT-Norge og HOD
Tomorrow’s Lab Today: Focus areas for medical biology and diagnostic testing ...Serene Touma
Healthcare will require a new approach and tools to support new patient expectations in 2020. A patient-centric approach to healthcare will be more relevant than ever.
Covid-19 has uncovered new challenges and weaknesses in care that are dependent on a centralized set-up.
What is becoming more and more clear is that diagnostic labs need to evolve and up their game to stay relevant. This will continue to bring value to patients throughout the healthcare journey.
A key focus in 2021 will be taking a look at building and maintaining better relationships between private and public players in patient care.
Healthcare, from Products to Solutions Exploring some of the latest initiativ...Alix Aubert
with high-level healthcare executives. Today, through Life Science Talks, we have decided to make some of this information available
to the professional community at large, provided it is non-confidential, of public interest, and likely to spark interesting partnerships in
the future.
This white paper therefore condenses data drawn from a number of informative meetings with decision makers in the European
healthcare sector during 2013 and 2014. More specifically, it is the result of an edition of Life science Talks dedicated to this subject
and held in Paris, in May 2014.
The discussions at this event were admirably moderated by Silvia Ondategui Parra, partner at EY, and were punctuated by keynotes
from leading stakeholders in European healthcare: Emmanuel Gomez, CNAM-TS, Head of Disease Management Programmes; Dr Rick
Greville, ABPI, Director of Wales and International Affairs; Thierry Zylberberg, Orange, Head of Orange Healthcare; Miguel Bernabeu,
Alcon (Novartis), Global Head of Market Access, Pricing and HEOR; Yvoine McCourt, Air Liquide, Head of Home Healthcare
International Development; Olivier Croly, GE Healthcare IT, GM Europe. Again, we thank them for sharing their views, their concerns,
and for outlining their projects in Europe within our forum.
Biocat is the institution that brings together the life sciences and healthcare innovation community in Catalonia.
Created in 2006 at the behest of the Government of Catalonia, Biocat’s mission is to maximize the economic and social impact of the life sciences and healthcare innovation of the BioRegion.
Biocat focuses its strategy on different key points:
- Raising awareness and promoting the ecosystem, creating tools and strategies for improving the knowledge of the Catalan healthcare sector and increasing its projection both at home and abroad, with the aim of positioning the BioRegion as an international reference.
- Providing innovative training and developing talent, by designing and executing programs and initiatives to improve talent and entrepreneurship considered essential factors for the growth of the sector.
- Accelerating technology transfer and business growth by supporting and carrying out activities for increasing the value of the sector, placing special emphasis on the added value of research, knowledge and technology transfer, internationalization and access to capital.
The BioRegion is the healthcare and life sciences ecosystem in Catalonia, meaning the group of companies, research groups and bodies, hospitals, universities, administrations, researchers and entrepreneurs, innovation and knowledge-transfer support structures working in Catalonia in this strategic sector.
With a population of more than 7.5 millions and territory comparable to that of European countries like Belgium or the Netherlands, Catalonia has the most dynamic life sciences ecosystem in Spain and one of the most active in Europe. Biocat is the body responsible for dynamizing and promoting the BioRegion of Catalonia.
Keynote conference during the Biocat Report 2017, by Dr. Daria Tataj, Founder of a strategy firm Tataj Innovation, and Chairwoman of the RISE High-Level Advisors to Carlos Moedas, European Commissioner for Research, Science and Innovation
Panel discussion: Being a successful healthcare entrepreneur: lessons from Boston to Barcelona, with numerous experts from CIMIT, Boston, in economics, development and strategic planning of medical devices; in prototypes and patents and founders of several startups.
Toby Reid, Managing Director at BioCity Scotland, was the keynote speaker of the Graduation Cerimony of d·HEALTH Barcelona 2017.
BioCity is UK's largest bioscience incubation centre. Over 200 companies are based in a BioCity Group business incubator, with a 91% survival rate of companies.
Presentation of Mehrdad Hariri (Canadian Science Policy Centre (CPSC), CEO & President) at the Forum of the BioRegion of Catalonia, organized by Biocat.
Presentation of Zayna Khayat (MaRS Discovery District, Health System Innovation; MaRS EXCITE) at the Forum of the BioRegion of Catalonia, organized by Biocat.
Presentation of Susan Bannister (Massachusetts Life Sciences Center, Former President and CEO) at the Forum of the BioRegion of Catalonia, organized by Biocat.
Presentation of Vishal Gulati (Draper Esprit, Venture Partner; Horizon Discovery Group PLC, Board Director) at the Forum of the BioRegion of Catalonia, organized by Biocat.
Presentation of Simon Howell (Founding Non-Executive Director of MedCity and Guy’s Campus Dean at King’s College London King’s College London) at the Forum of the BioRegion of Catalonia, organized by Biocat.
The Health & Bio Team Dating project was created through the collaboration of four institutions: Banc Sabadell, the fifth-largest Spanish banking group, Biocat, Bosch i Gimpera Foundation and CataloniaBio, three bodies representing the life sciences sector in Catalonia.
The initiative aims to dynamize and promote the development of the Catalan bioentrepreneurial ecosystem by linking entrepreneurs with projects.
We expect this event to lead to formal collaborations between business professionals and research groups in balanced management teams to create new life sciences start-ups with high potential.
The BioRegion of Catalonia, a research and innovation hub in Southern Europe, participated at BIO 2015 in Philadelphia. Check the profile of delegation.
Presentation given by Iñaki Largo from the Technology Transfer Office of the University of the Basque Country in the framework of the Emergence Forum Barcelona
Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation.
More information at: http://www.b2match.eu/emergenceforum2014
Presentation given by Fernando Javier Conesa from Polytechnic University of Valencia in the framework of the Emergence Forum Barcelona
Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation.
More information at: http://www.b2match.eu/emergenceforum2014
Presentation given by Jean-Pierre Saintouil from Toulouse Tech Transfer in the framework of the Emergence Forum Barcelona
Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation.
More information at: http://www.b2match.eu/emergenceforum2014
Presentation given by Vicenç Tur from Lipopharma Therapeutics in the framework of the Emergence Forum Barcelona
Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation.
More information at: http://www.b2match.eu/emergenceforum2014
Presentation given by Laura Coll from the UAB Institut de l'Envelliment in the framework of the Emergence Forum Barcelona
Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation.
More information at: http://www.b2match.eu/emergenceforum2014
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Presentation Moebio 2018
1. 1
A POSGRADUATE PROGRAM TO
DEVELOP ENTREPRENEURS AND
CREATIVE LEADERS IN
HEALTHCARE INNOVATION
One of the very few programs
promoting medical device
innovation worldwide
2. 2
Drugs
Patent Cliff
Pharma
Expenditure
Control
Higher
Barriers
of Entry
Interoperability
Lack of HCP’s
Digital Culture
Low success of
Internal R&D
results
M&A
Technology
Public Purchase
Beyond
the PILL
Patient
Empowerment
The life sciences and healthcare industry is
immersed in a period of transformation
Open Innovation is a tool to reinvent and to achieve better results,
and to meet new business needs
4. 4
RESEARCH
COMPANIES
&
START-UPS
ADMINISTRATION
CAPITAL
TALENT
PROGRAMS
Biocat dynamizes all the stakeholders of the
BioRegion to transform knowledge and technology
into economic growth, and to create a social impact
STRATEGY:
• SHARING KNOWLEDGE AND PROMOTING THE
BIOREGION
• ACCELERATING ENTREPRENEURSHIP AND
COMPANIES GROWTH
• TECHNOLOGY TRANSFER AND VALORISATION
Biocat acts as a strategic agent
and catalyst of the Catalan
healthcare and life sciences
ecosystem
KEY ELEMENTS OF THE BIOREGION
5. 5
THE BIOREGION OF CATALONIA:
A GROWING HEALTHCARE AND
LIFE SCIENCES ECOSYSTEM
6. 6
Source: Biocat Directory (Feb. 2017)
871COMPANIES
95RESEARCH
ORGANIZATIONS
Excellence in research & a strong entrepreneurial
spirit: key drivers in the development of the BioRegion
8. 8
Is the talent development initiative of
Biocat to accelerate healthcare
entrepreneurship
Is the full-time program of MOEBIO,
inspired and modeled in the
prestigious Stanford University's Biodesign
Fellowship that seeks to train a team of
fellows in the process of biodesign to
develop innovative solutions
Our goals:
• Promote innovation within the healthcare sector (ecosystem program)
• Train and provide talent to the life science sector
• Create startups with valuable products and business models
• Collaborate and scale the program at European level
• Position the BioRegion at international level
BIOCAT develops programs to accelerate
healthcare entrepreneurship
9. 9
Inspired in the prestigious Stanford University’s Biodesign Fellowship, d·HEALTH
Barcelona is a 9-month Program which provides disruptive education, training
and mentorship to 12 multidisciplinary Fellows (with backgrounds in Health, Bio,
Tech, Business, Engineering and Design) into healthcare entrepreneurs.
After a clinical immersion in a top hospital of Barcelona, fellows select the most
valuable unmet healthcare needs and transform them into innovative solutions,
through the biodesign methodology. They identify, invent and implement a viable
business proposition to be place in the market.
Fellows receive training in subjects such as design thinking or creative
leadership through classes taught by over 50 international experts. They also
benefit from the vibrant BioRegion ecosystem and are able to attend the most
interesting events to improve their learning process and network with other
entrepreneurs and KOL.
“Are you working on something that can change the world? Yes or no? For 99% of the people on the planet,
the answer is no, and the fact of the matter is, we should be” Larry Page - co-founder of Google
d·HEALTH Barcelona: Transforming real unmet
needs into innovative marketable solutions
10. 10
BIODESIGN CREATIVE LEADERSHIPLEAN STARTUP
A process to innovate
in med tech
A methodology to being
less wasteful and still
doing things that are big
An approach to leading
& soft skills
Join a successful methodologies to enrich
medtech innovation
11. 11
2014
2015
2016
2017
(ONGOING EDITION)
ICT
(Thorax Institute)
Neonatology Functional
rehabilitation
ICMDiM
(Institute of Digestive
and Metabolic Diseases)
ICOF
(Institute Ophthalmology)
Cardiology
Functional
rehabilitation
Gynecology and
Obstetrics
ICNU
(Institute Nephrology and
Urology)
Functional
rehabilitation
Endocrinology
9 projects developed after the 3 first editions
The 5th edition of d·HEALTH Barcelona will be launched on January 2018
12. 12
Product: Solution for chronic constipation in the form of a
wearable medical device that simulates the techniques of
professional massage therapists
Current status: On the market. Company incorporated in
2014 (usMIMA)
Team: Institut Guttmann, 2013-2014
Both projects have obtained funding from H2020, through the SME
instrument. In total, the funds raised are 2,3 M €
Product: Medical device for anal incontinence
Current status: Product development. Company’s incorporation
expected for the end of 2016
Team: Hospital Clínic, 2015
Our success stories
13. 13
Through over 3,000 unmet clinical needs and more
than 1,250 interviews, we are improving healthcare
at a systemic level
14. 14
The teams develop a deep analysis on the final top 12 needs selected
Information included in the report:
Definition of the problem (data on
prevalence, incidence…)
Clinical impact (cost of the clinical
problem…)
Analysis on the current solutions
(analysis of current treatments, risk and
benefits of each of them, unmet needs
of the current solutions, weaknesses of
the current treatments and potential
opportunities of innovation…)
Stakeholder analysis
Discovering, understanding & reformulating
unmet clinical needs to transform them into
valuable knowledge
15. 15
More than 70 experts from all over the world
collaborating with the program
16. 16
More than 70 experts from all over the world
collaborating with the program
17. 17
• 1ST Prize BIOEMPRENEDOR XXI (2014)
• 1ST Prize Biotecnología y Salud del Everis Award
(2015)
• “TOP 10 innovative startups with social impact in
Spain” by TEDx Binnenhof/European
Commission and ENISA (2015)
• “Seal of Excellence” of the European
Commission/Horizon 2020 (2016)
• Head start Proof of concept EIT Health Award
(2016)
• Unique Spanish company participating in
MassChallenge UK accelerator
Our companies are recognised both at national
and international level
18. 18
1. Digitalhealth.careers (https://goo.gl/ygwx5P )
2. Mobile World Capital (https://goo.gl/NbqRai )
3. Tech EU (https://goo.gl/kZPIOD )
4. HealthStartup (https://goo.gl/My2y3z )
MOEBIO is ranked as one of the most important
accelerators in Europe
19. 19
NOW THAT YOU KNOW THAT
WE HAVE A SUCCESSFUL AND
REKNOWED PROGRAM,
WHAT CAN WE DO FOR YOU?
20. 20
Set of Proposals:
1. Become a PARTNER OF d·HEALTH Barcelona
2. Enjoy the TRAINING LESSONS in life sciences and healthcare addressed to improve your people’s
knowledge & skills
3. Become a SPONSOR OF d·HEALTH Barcelona
We are looking for partners to join d·HEALTH
Barcelona and benefit from its outcomes
21. 21
What do we offer you:
BUSINESS
OPORTUNITIES
BRAND
RECOGNITION
TRAINING
• Priority access to innovative business opportunities (final solution)
• Right of first look to the top clinical needs identified during the program
(needs top 12 and top 50)
• Have a “business liaison” working closely with of one the teams
• Clinical setting knowledge: reinforce the company knowledge of the current
dynamics and future trends of the main clinical areas of the hospitals
• Meeting with the KOL professionals
• Training in innovative methodologies developed at the hospitals
• Exclusive access to a limited number of lessons/workshops of interest of the
company included in the d·HEALTH learning program
• 2 Invitations to attend 10 sessions of the training package opened to the
ecosystem: the Short Programs
• Visibility in all d·HEALTH marketing materials (website, leaflets, e-mailings,
social media, press releases and events)
22. 22
Short Programs: learn from the best d·HEALTH
BARCELONA classes
MOEBIO Short Programs are educational programs of maximum 20 hours covering key aspects in
healthcare, innovation, management and entrepreneurship. Short programs are addressed at
professionals willing to broaden their skills set and acquire new practical knowledge about today’s
most pressing issues, and this over a short period of time.
Short programs are
addressed to…
Entrepreneurs, managers
and executives of healthcare
organizations, students,
recent graduates and other
professionals interested in
expanding their areas of expertise
to healthcare and
entrepreneurship
2017 edition:
1.Understanding Healthcare Systems
2.Update on the Life Sciences Industry
3.Entrepreneurship and Management
4.Medical Devices I: Product Development
5.Medical Devices II: Market access
“Exclusive classes” are also part of the d·HEALTH Barcelona program
(with Fellows), but cannot be bought by the general public